 | Up a level |
Fister, S; Günthert, AR; Aicher, B; Paulini, KW; Emons, G; Gründker, C (2009). GnRH-II antagonists induce apoptosis in human endometrial, ovarian and breast cancer cells via activation of stress-induced MAPKs p38 and JNK and proapoptotic protein Bax. Cancer research, 69(16), pp. 6473-6481. Birmingham, Ala.: American Association for Cancer Research AACR 10.1158/0008-5472.CAN-08-4657
Fister, S; Schlotawa, L; Günthert, AR; Emons, G; Gründker, C (2008). Increase of doxorubicin-induced apoptosis after knock-down of gonadotropin-releasing hormone receptor expression in human endometrial, ovarian and breast cancer cells. Gynecological endocrinology, 24(1), pp. 24-29. London: Informa Healthcare 10.1080/09513590701668882
Gründker, C; Günthert, AR; Emons, G (2008). Hormonal heterogeneity of endometrial cancer. Advances in experimental medicine and biology(630), pp. 166-188. Wien: Springer
Fister, S; Günthert, AR; Emons, G; Gründker, C (2007). Gonadotropin-releasing hormone type II antagonists induce apoptotic cell death in human endometrial and ovarian cancer cells in vitro and in vivo. Cancer research, 67(4), pp. 1750-1756. Birmingham, Ala.: American Association for Cancer Research AACR 10.1158/0008-5472.CAN-06-3222
Gründker, C; Günthert, AR; Emons, G (2007). Hormonal heterogeneity of endometrial cancer. In: Berstein LM, Santen RJ (ed.) Innovative Endocrinology of Cancer. Austin, Texas: Landes Bioscience
